Zhengye Biotechnology Holding Limited (ZYBT)

NASDAQ: ZYBT · Real-Time Price · USD

1.890

-0.200 (-9.57%)

At close: Aug 7, 2026, 4:00 PM EDT

1.830

-0.060 (-3.17%)

After-hours: Aug 7, 2026, 7:59 PM EDT

ZYBT Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-82.97	13.47	37.51	55.74	46.47
Depreciation & Amortization	25.88	24.16	23.91	18.8	16.01
Other Adjustments	25.59	4.39	7.04	9.39	3.04
Change in Receivables	60.67	12.59	39.35	-47.37	-40.68
Changes in Inventories	6.25	-5.88	-12.9	-12.33	-12.34
Changes in Accounts Payable	-3.36	-0.4	-35.61	-9.67	17.63
Changes in Accrued Expenses	0.42	2.7	-0.58	0.21	0.52
Changes in Income Taxes Payable	0.28	-0.23	-7.7	3.19	0.8
Changes in Unearned Revenue	1.27	-0.4	-0.72	0.32	1.4
Changes in Other Operating Activities	-20.7	-9.35	-2.12	-0.94	-1.04
Operating Cash Flow	13.33	41.05	48.18	17.34	31.81
Operating Cash Flow Growth	-67.52%	-14.81%	177.96%	-45.50%	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-1.01	-13.59	-7.4	-27.33	-19.06
Sale of Property, Plant & Equipment	-	0.11	1.06	-	0.13
Purchases of Intangible Assets	-11.62	-14.19	-4.2	-	-7.34
Purchases of Investments	-	-	-1.22	-	-
Investing Cash Flow	-12.63	-27.67	-11.77	-27.33	-26.27

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	70.47	90.12	79.86	99.85	30
Long-Term Debt Repaid	-82.56	-92.86	-54.89	-64.97	-22
Net Long-Term Debt Issued (Repaid)	-12.09	-2.74	24.97	34.88	8
Issuance of Common Stock	44.55	-	-	-	-
Net Common Stock Issued (Repurchased)	44.55	-	-	-	-
Common Dividends Paid	-	-16.02	-39.45	-21.43	-11.05
Other Financing Activities	-0.15	-3.37	-4.5	-	-
Financing Cash Flow	32.31	-22.13	-18.98	13.46	-3.05

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-1.29	0.17	-	-	-
Net Cash Flow	31.73	-8.58	17.44	3.46	2.49

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	12.33	27.46	40.79	-9.99	12.75
Free Cash Flow Growth	-55.12%	-32.68%	-	-	-
FCF Margin	10.59%	14.73%	19.27%	-3.84%	5.95%
Free Cash Flow Per Share	0.26	0.60	0.89	-0.22	0.28
Levered Free Cash Flow	-72.85	5.58	13.31	53.86	58.39
Unlevered Free Cash Flow	-72.36	12.39	-4.56	29.66	49.79

SEC Filings: 10-K · 10-Q